ReAlta Life Sciences: funding roundDevelops first-in-class peptides for inflammatory disordersOct 4, 2026RoundOSReAlta Life SciencesCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesHealthtechNorth AmericaUndisclosed